Low-level laser or LED photobiomodulation on oral mucositis in pediatric patients under high doses of methotrexate: prospective, randomized, controlled trial
- 24 April 2021
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 29 (11) , 6441-6447
Abstract
Purpose The objective of the present study was to compare the efficacy of photobiomodulation with low-level laser therapy (LLLT) or light-emitting diode therapy (LEDT) devices for the prevention and treatment of oral mucositis in pediatric patients diagnosed with acute lymphoblastic leukemia undergoing chemotherapy with high doses of methotrexate (MTX). Methods Eighty patients were randomly divided into two groups: LLLT and LEDT. Both protocols were applied with the same energy and radiant exposure. The protocols started in the beginning of high doses MTX and finished when the patients were discharged from the hospital or there was oral mucositis resolution. The oral mucositis was assessed during each session in accordance to the World Health Organization (WHO) score. The patients’ self-assessed pain was scored on a visual analog scale (VAS). Results The incidence of oral mucositis was similar to LLLT and LEDT, 10% and 12.5%, respectively. Both groups required the same number of days to reach score of zero for mucositis and pain (p > 0. 05), and there was no significant difference in mean VAS between the groups. Conclusions These findings suggest that LEDT has similar effects to LLLT to avoid and treat oral mucositis. Brazilian Clinical Trial Registry with #U1111-1221-5943Keywords
This publication has 28 references indexed in Scilit:
- MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapyCancer, 2020
- Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelinesSupportive Care in Cancer, 2019
- A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patientsEuropean Journal of Pediatrics, 2017
- Oral Cryotherapy for Preventing Oral Mucositis in Patients Receiving Cancer TreatmentJAMA Oncology, 2016
- Severe neurotoxicity following intrathecal methotrexate with nitrous oxide sedation in a child with acute lymphoblastic leukemiaPediatric Blood & Cancer, 2014
- MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapyCancer, 2014
- Oral mucosal injury caused by cancer therapies: current management and new frontiers in researchJournal of Oral Pathology & Medicine, 2013
- Systematic review of laser and other light therapy for the management of oral mucositis in cancer patientsSupportive Care in Cancer, 2012
- Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemiaInt. Journal of Clinical Pharmacology and Therapeutics, 2008
- High‐dose methotrexate therapy of childhood acute lymphoblastic leukemia: Lack of relation between serum methotrexate concentration and creatinine clearancePediatric Blood & Cancer, 2004